Odyssey Therapeutics to present additional Phase 2a OD-001 ulcerative colitis induction data at UEG Week 2026PUBT·Oct 6, 2026 at 12:01 PMODTX-0.28%
Odyssey Therapeutics to present at Stifel Virtual Immunology and Inflammation ForumPUBT·Sep 16, 2026 at 12:01 PMODTX-0.28%SF-0.58%
Biotech Stocks At 52-Week Highs - PDEX +18% On FY'26 Results, ODTX +8%, EOLS, BFRI, DRTSrttnews·Sep 8, 2026 at 02:33 AMBFRI+0.36%PDEX-3.27%
This Ascendis Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursdaybenzinga_article·Aug 27, 2026 at 02:52 PMASND+1.04%ODTX-0.28%
Odyssey Therapeutics management to join Morgan Stanley Global Healthcare Conference fireside chatPUBT·Aug 26, 2026 at 12:06 PMMS-0.69%ODTX-0.28%
Odyssey Therapeutics (ODTX) Stock Looks Reasonable As AI Research News LandsSimplywall·Aug 9, 2026 at 07:30 PMODTX-0.28%EVO-1.23%
Odyssey Therapeutics (NASDAQ:ODTX) Given New $29.00 Price Target at JPMorgan Chase & Co.Market Beat·Aug 7, 2026 at 04:42 PMODTX-0.28%
Evotec and Odyssey collaborate on AI-enabled R&DPharmaceutical Technology·Aug 7, 2026 at 09:10 AMODTX-0.28%EVO-1.23%
Biotech Stocks At 52-Week Highs - BVS, TVTX, ODTX, CRL Climb With Q2 Results, ACRSrttnews·Aug 6, 2026 at 08:55 AMACRS-8.11%CRL-1.53%
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases | EVO Stock NewsStockTitan·Aug 5, 2026 at 10:16 PMODTX-0.28%EVO-1.23%
